The effect of ascorbic acid supplementation on the nicotine metabolism of smokers

被引:6
作者
Dawson, EE [1 ]
Evans, DR [1 ]
Harris, WA [1 ]
McGanity, WJ [1 ]
机构
[1] Univ Texas, Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA
关键词
ascorbic acid; nicotine metabolite excretion; smoking;
D O I
10.1006/pmed.1999.0583
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. The relationship of serum ascorbic acid (AA) levels and excretion of nicotine metabolites was determined in 75 men who smoked at least one pack of cigarettes per day. Methods. The subjects were randomly divided into three groups of 25 each who received a placebo, 200 mg of supplementation, or 1000 mg of supplementation of AA per day for 1 month. Baseline and weekly serum AA levels were determined and simultaneous estimates of urinary excretion of nicotine metabolites as cotinine equivalents (CE), Results. The group mean serum AA levels in the placebo group decreased 13% after 2 weeks; the group mean serum levels of the supplemented groups increased significantly after 1 week (P less than or equal to 0.001) and remained elevated over 100% per week from baseline throughout the study. There was a progressive increase in urinary CE: excretion in the placebo group. In the supplemented groups, group mean CE excretion decreased an average of 5% weekly in the 200-mg group and an average of 33% weekly in the 1000-mg group, Pearson's correlation between serum AA and urine CE excretion was significant (r = -0.7980, P less than or equal to 0.0003). Conclusions. Body levels of AA affect the level of urinary nicotine metabolites. The results of this study indicate that dietary levels of AA are inversely correlated to urinary excretion of nicotine metabolites and may be due to suppressed: (1) nicotine intake by smokers who smoked fewer cigarettes or inhale less deeply, (2) nicotine metabolism, or (3) both. (C) 1999 American Health Foundation and Academic Press.
引用
收藏
页码:451 / 454
页数:4
相关论文
共 20 条
[1]  
BARLOW RD, 1987, CLIN CHIM ACTA, V165, P15
[2]   NICOTINE AND COTININE ELIMINATION PHARMACOKINETICS IN SMOKERS AND NONSMOKERS [J].
BENOWITZ, NL ;
JACOB, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (03) :316-323
[3]  
BENOWITZ NL, 1994, J PHARMACOL EXP THER, V268, P296
[4]   CIRCADIAN BLOOD NICOTINE CONCENTRATIONS DURING CIGARETTE-SMOKING [J].
BENOWITZ, NL ;
KUYT, F ;
JACOB, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (06) :758-764
[5]   DAILY INTAKE OF NICOTINE DURING CIGARETTE-SMOKING [J].
BENOWITZ, NL ;
JACOB, P .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (04) :499-504
[6]  
BENOWITZ NL, 1982, J PHARMACOL EXP THER, V221, P386
[7]   THE EFFECT OF ASCORBIC-ACID ON THE MEASUREMENT OF TOTAL CHOLESTEROL AND TRIGLYCERIDES - POSSIBLE ARTIFACTUAL LOWERING IN INDIVIDUALS WITH HIGH PLASMA-CONCENTRATION OF ASCORBIC-ACID [J].
BENZIE, IFF ;
STRAIN, JJ .
CLINICA CHIMICA ACTA, 1995, 239 (02) :185-190
[8]  
CURVALL M, 1989, 43 TOB CHEM RES C RI
[9]   A COMPARISON OF SERUM FREE ESTRIOL WITH SPONTANEOUS URINE TOTAL ESTROGEN AND ESTROGEN CREATININE RATIO [J].
DAWSON, EB ;
SIMMONS, JE ;
NAGAMANI, M .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1983, 21 (05) :371-375
[10]  
DAWSON EB, 1992, FERTIL STERIL, V58, P1034